Inefficacy of topical alpha interferon in the treatment of oral ulcers of behçet's syndrome: A randomized, double blind trial

Rheumatology

Volumn 30, Issue 5, 1991, Pages 395-396

  Hamuryudan, V ^a   Yurdakul, S ^a   Rosenkaimeri, F ^b   Yazici, H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Boehringer Ingelheim Zentrale GmhH ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

BEHCET DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYDROGEL; LETTER; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; BEHCET SYNDROME; DOUBLE-BLIND METHOD; FEMALE; HUMAN; INTERFERON TYPE I, RECOMBINANT; MALE; STOMATITIS, APHTHOUS;

EID: 0026338043     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/30.5.395-a     Document Type: Letter

References (11)

1. Schumacher HR. Ochronosis, haemochromatosis and Wilson’s disease. In: McCarty DJ, ed. Arthritis and allied conditions. 10th ed. Philadelphia: Lea and Febiger, 1985: 1565-78.
2. Adamson TC, Resnik CS, Guerra Jr J, Vint VC, Weisman MH, Resnick D. Hand and wrist arthropathies of haemochromatosis and calcium pyrophosphate deprosition disease: distinct radiological features. Radiology 1983;147:377-81.
3. Myers AR. Septic arthritis caused by bacteria. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. 2nd ed. Philadelphia: WB Saunders, 1985:1507-27.
4. Bullen JJ, Griffiths E. Iron and infection. New York: John Wiley and Sons, 1987.
5. Muench KH. Haemochromatosis and infection: alcohol and iron, oysters and sepsis. Am J Med 1989;87(Suppl 3):40N-53N.
6. Glezenman M, Lunenfeld E, Cohen V, el al. Placebo controlled trial of topical interferon in labial and genital herpes. Lancet 1988;1: 150-2.
7. Young C, Lehner T, Barnes CG. CD4 and CDScell responses to herpes simplex virus in Behçet’s disease. Clin Exp Immunol 1988;73:6-10.
8. Denman AM, Fialkow PJ, Peiton BK, Salo AC, Appleford DJ, Gilchrist C. Lymphocyte abnormalities in Behçet’s syndrome. Clin Exp Immunol 1980;42:175-85.
9. Hamuryudan V, Yurdakul S, Serdaroglu S, Tuzun Y, Rose- nkàimer F, Yazici H. Topical alpha interferon in the treatment of oral ulcers in Behçet’s syndrome: a preliminary report. Clin Exp Rheumatol 1990;8:51-61.
10. Lehner T. Recurrent oral ulcers and Behcet’s syndrome: pathological immunological and clinical study MD Thesis, University of London, 1968.
11. Yazici H, Tüzün Y, Pazarh H, el al. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis 1984;43:783-9.